Everolimus for subependymal giant cell astrocytoma in patients with tuberous sclerosis complex: 2-year open-label extension of the randomised EXIST-1 study.

Journal: The Lancet. Oncology

Publication Year: 2015

Authors & Co-authors:  Franz David Neal DN Belousova Elena E Sparagana Steven S Bebin E Martina EM Frost Michael M Kuperman Rachel R Witt Olaf O Kohrman Michael H MH Flamini J Robert JR Wu Joyce Y JY